Baldermann H, Wicklmayr M, Rett K, Banholzer P, Dietze G, Mehnert H
III. Medizinische Abteilung, Krankenhauses München-Schwabing.
Infusionstherapie. 1988 Aug;15(4):140-3.
Fatty infiltration of the liver with cholestasis is one of the complications of total parenteral nutrition (TPN). The casualty has not yet been determined. It seems probable, however, that these alterations could be prevented when a mixture of medium- and long-chain triglycerides (MCT/LCT) is used as fat component of TPN instead of the application of long-chain emulsions (LCT) alone. To determine whether this could be demonstrated also morphologically in man, 14 patients needing TPN (25 kcal/kg BW x d, CH 45%, F 35%, P 20%) were examined with ultrasound in order to compare liver-size and grey-scale value before and after 7 days of TPN. Seven of the patients were randomly given as their fat-intake an MCT/LCT-emulsion, the other 7 LCT exclusively. There were no changes in liver size and grey-scale value in the MCT/LCT-group, whereas both parameters showed a significant rise in the patients with LCT (size: 10.4 +/- 1.4 to 11.5 +/- 1.4 cm; grey-scale value: 9.3 +/- 1.0 to 11.6 +/- 0.7). These data suggest that TPN, administered with a mixture of MCT/LCT emulsions as fat component, could reduce the risk of hepatic dysfunction such as cholestasis and fatty infiltration of the liver.
伴有胆汁淤积的肝脏脂肪浸润是全胃肠外营养(TPN)的并发症之一。其病因尚未明确。然而,当使用中长链甘油三酯混合物(MCT/LCT)作为TPN的脂肪成分而非仅使用长链乳剂(LCT)时,这些改变似乎是可以预防的。为了确定在人体中是否也能从形态学上得到证实,对14例需要TPN的患者(25千卡/千克体重×天,碳水化合物45%,脂肪35%,蛋白质20%)进行了超声检查,以比较TPN 7天前后的肝脏大小和灰度值。7例患者随机给予MCT/LCT乳剂作为脂肪摄入,另外7例仅给予LCT。MCT/LCT组的肝脏大小和灰度值没有变化,而LCT组患者的这两个参数均显著升高(大小:10.4±1.4至11.5±1.4厘米;灰度值:9.3±1.0至11.6±0.7)。这些数据表明,以MCT/LCT乳剂混合物作为脂肪成分给予TPN,可以降低诸如胆汁淤积和肝脏脂肪浸润等肝功能障碍的风险。